Natixis Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.8M | Buy |
|
|||||
|
2025
Q1 | $3.68M | Buy |
|
|||||
|
2024
Q4 | $2.59M | Sell |
|
|||||
|
2024
Q3 | $4.8M | Sell |
|
|||||
|
2024
Q2 | $8.07M | Buy |
|
|||||
|
2024
Q1 | $5.41M | Buy |
|
|||||
|
2023
Q4 | $6.25M | Buy |
|
|||||
|
2023
Q3 | $6.07M | Sell |
|
|||||
|
2023
Q2 | $8.07M | Buy |
|
|||||
|
2023
Q1 | $7.38M | Buy |
|
|||||
|
2022
Q4 | $6.12M | Buy |
|
|||||
|
2022
Q3 | $5.67M | Buy |
|
|||||
|
2022
Q2 | $3.64M | Buy |
|
|||||
|
2022
Q1 | $3.34M | Sell |
|
|||||
|
2021
Q4 | $3.94M | Sell |
|
|||||
|
2021
Q3 | $6.2M | Buy |
|
|||||
|
2021
Q2 | $6.93M | Buy |
|
|||||
|
2021
Q1 | $5.41M | Buy |
|
|||||
|
2020
Q4 | $4.71M | Sell |
|
|||||
|
2020
Q3 | $24.7M | Buy |
|
|||||
|
2020
Q2 | $22.9M | Sell |
|
|||||
|
2020
Q1 | $31.8M | Buy |
|
|||||
|
2019
Q4 | $26.5M | Sell |
|
|||||
|
2019
Q3 | $21M | Buy |
|
|||||
|
2019
Q2 | $19.7M | Buy |
|
|||||
|
2019
Q1 | $14M | Sell |
|
|||||
|
2018
Q4 | $21.9M | Sell |
|
|||||
|
2018
Q3 | $28.8M | Buy |
|
|||||
|
2018
Q2 | $23.5M | Buy |
|
|||||
|
2018
Q1 | $21.9M | Buy |
|
|||||
|
2017
Q4 | $22.1M | Buy |
|
|||||
|
2017
Q3 | $20.3M | Buy |
|
|||||
|
2017
Q2 | $16.4M | Buy |
|
|||||
|
2017
Q1 | $16.1M | Buy |
|
|||||
|
2016
Q4 | $15.5M | Buy |
|
|||||
|
2016
Q3 | $14.5M | Sell |
|
|||||
|
2016
Q2 | $11.6M | Buy |
|
|||||
|
2016
Q1 | $11.7M | Buy |
|
|||||
|
2015
Q4 | $11.5M | Sell |
|
|||||
|
2015
Q3 | $14.5M | Buy |
|
|||||
|
2015
Q2 | $19.4M | Buy |
|
|||||
|
2015
Q1 | $18.5M | Buy |
|
|||||
|
2014
Q4 | $14.4M | Buy |
|
|||||
|
2014
Q3 | $12.5M | Buy |
|
|||||
|
2014
Q2 | $7.63M | Buy |
|
|||||
|
2014
Q1 | $7.27M | Buy |
|
|||||
|
2013
Q4 | $6.15M | Buy |
|
|||||
|
2013
Q3 | $5.05M | Buy |
|
|||||
|
2013
Q2 | $4.4M | Buy |
|